Farms.com Home   News

Canada to resume exports of PEI potatoes to United States

Prince Edward Island farmers will soon be able to resume exporting potatoes to the United States, months after Canada suspended shipments because of the detection of potato wart in fields on the Island.

The United States Department of Agriculture issued a news release today stating the two countries have reached an understanding.

The USDA says exports of P.E.I. table-stock potatoes can resume under certain conditions, including that potatoes shipped to the U.S. come only from fields not known to be infested with potato wart.

Canada halted the export of potatoes from P.E.I. last November to avoid a U.S. ban, and the continental United States market has been closed to all Island potatoes ever since. Exports to Puerto Rico resumed last month.

The P.E.I. Potato Board has said the Island's potato industry lost more than $25 million before exports to Puerto Rico resumed.

Potato wart is a fungal parasite that spreads through the movement of infected potatoes, soil and equipment, and though it poses no threat to human health, it leaves potatoes disfigured and can decrease crop yields.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.